Inhibrx Inc

NASDAQ:INBX  
28.19
+0.19 (+0.68%)
Products

Inhibrx Receives FDA Orphan-Drug Designation For INBRX-109 In Chondrosarcoma

Published: 12/01/2021 21:21 GMT
Inhibrx Inc (INBX) - Inhibrx Receives FDA Orphan-drug Designation for Inbrx-109 in Chondrosarcoma.